Wada, Takehiko http://orcid.org/0000-0001-9740-5183
Shimizu, Sayaka
Koizumi, Masahiro
Sofue, Tadashi
Nishiwaki, Hiroki
Sasaki, Sho
Nakaya, Izaya
Oe, Yuji
Ishimoto, Takuji
Furuichi, Kengo
Okada, Hirokazu
Kurita, Noriaki
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (20FC1045)
Article History
Received: 23 April 2023
Accepted: 28 May 2023
First Online: 13 June 2023
Declarations
:
: Honoraria: Hirokazu Okada (AstraZeneca, Daiichi Sankyo, Kyowa Kirin, Mitsubishi Tanabe Pharm, Torii Pharmaceutical), Noriaki Kurita (GlaxoSmithKline), Research funding: Kengo Furuichi (Chugai Pharmaceutical, Daiichi Sankyo), Hirokazu Okada (Kyowa Kirin), Subsidies or donations: Hirokazu Okada (Bayer, Chugai Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical).
: This study was an anonymous survey of healthcare professionals to describe the practice of primary nephrotic syndrome and was considered outside the scope of the ethical review according to the Ethical Guidelines for Medical and Biological Research Involving Human Subjects [CitationRef removed]. The possibility of academic publication of the survey results was described at the beginning of the questionnaire, and only those who provided consent to complete the survey were included.